How to improve outcomes?
DOI:
https://doi.org/10.47196/diab.v56i3Sup.541Keywords:
pregnancy, diabetes mellitusAbstract
There is a growing volume of evidence that supports the importance of treatment of Gestational Diabetes Mellitus as risk reducers of perinatal complications (such as respiratory distress, hypoglycemia, hyperbilirubinemia, etc). Although the focus is on fetal macrosomia and future appearance of chronic noncommunicable diseases, we know that the effect can be modified by healthy family habits and optimal metabolic control.
In pregnant women with pregestational diabetes mellitus, preconceptional careis essential to avoid the risks of congenital malformations, hypoglycemia in the first trimester and illness progression.By insisting on the importance of adequate metabolic control prior to gestation, with metabolic optimization and the use of appropriate drugs, it is possible to achieve adecuate fetal growth and minimize the occurrence of adverse events.
References
-
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
